| Number of patients1 |  |  |  |  |  | |||
---|---|---|---|---|---|---|---|---|---|
 | A | B | C | D | SENS2 (95% CI) | SPEC3 (95% CI) | PPV4 (95% CI) | NPV5 (95% CI) | Accuracy6 |
MEONF-II in relation to MNA | 31 | 7 | 20 | 27 | .61 (.46-.74) | .79 (.62-.91) | .82 (.66-.92) | .57 (.42-.72) | .68 |
NRS 2002 in relation to MNA | 19 | 6 | 32 | 28 | .37 (.24-.52) | .82 (.65-.93) | .76 (.55-.91) | .47 (.34-.60) | .55 |
 | MNA |  |  |  |  |  | |||
Screening (MEONF-II or NRS 2002) | UN-risk/UN | Not at risk | Â | Â | Â | Â | Â | ||
UN-risk/UN | A | B | Â | Â | Â | Â | Â | ||
Not at risk | C | D | Â | Â | Â | Â | Â |